Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.
Cambridge Joins Consortium to Launch £40 Million Apollo Therapeutics Fund
Three global pharmaceutical companies and the technology transfer offices of three universities – Imperial College London, University College London and the University of Cambridge – have joined forces with a combined £40 million to create the Apollo Therapeutics Fund. This joint venture will support the translation of ground-breaking academic science from within these universities into innovative new medicines for a broad range of diseases. [University of Cambridge]